Digital Therapeutics Market Opportunities – Know the Untapped Growth Opportunities to 2028

 

Digital Therapeutics Market Insights:

In a recent research report by Market Research Community, the Digital Therapeutics Market is expected to surpass USD 10.01 Billion by the year 2028, from USD 5.20 Billion in 2021.

The Digital Therapeutics Market Share is projected to grow at a significant pace reaching a CAGR of approximately 9.8%, over the forecast period of 2022–2030, despite a considerable fall in product sales during the initial phase of the pandemic spread and lockdown restrictions imposed globally.

Digital therapeutics (DTx) is a rapidly growing field that involves the use of digital technologies such as mobile apps, software, and wearable devices to prevent, manage, and treat a wide range of medical conditions. These technologies are designed to deliver evidence-based interventions that can improve patient outcomes and reduce healthcare costs.

DTx solutions can be used for various indications, such as chronic disease management, mental health, and addiction treatment, and can be delivered to patients in a variety of ways, including through telemedicine, remote monitoring, and self-care.

Get Sample Report Here: https://marketresearchcommunity.com/sample-request/?rid=463

The study is consolidated into major segments and further into sub-segments, such as By Product Type (Software and Devices), By Application (Substance Abuse, Central Nervous Diseases (CNS), Multiple Sulfatase Deficiency (MSD), Gastrointestinal Disorder (GID), Diabetes, Obesity, Cardiovascular Diseases (CVD)), By Sales Channel (Business-to-Business (Providers, Pharmaceuticals Employer), Business-to Consumer (Caregiver, Patient)), to forecast the market size by value.

By Product Type

·        Software

·        Devices

By Application

·        Substance Abuse

·        Central Nervous Diseases (CNS)

·        Multiple Sulfatase Deficiency (MSD)

·        Gastrointestinal Disorder (GID)

·        Diabetes

·        Obesity

·         Cardiovascular Diseases (CVD)

By Sales Channel  

·        Business-to-Business (Providers, Pharmaceuticals Employer)

·        Business-to Consumer (Caregiver, Patient)

Digital Therapeutics Market Includes Key Players:

·        Medtronic Plc.

·        Livongo Health, Inc.

·        Omada Health, Inc.

·        Resmed, Inc. (Propeller Health)

·        Proteus Digital Health, Inc.

·        Fitbit Health Solutions

·        Pear Therapeutics, Inc.

·        2MORROW, Inc.

·        Welldoc, Inc.,Voluntis, Inc.

·        Canary Health Inc.

·        Noom, Inc.

Digital Therapeutics Market Size, and Asian nations are steadily emerging as a result of government policies that are favorable to this market and growing public understanding of the advantages of these systems. Further, regions such as the Latin America, and Europe Middle East and Africa, are expected to boost the market expansion during the forecast period.

By Region

•                    Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe)

•                    Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific)

•                    North America– (U.S., Canada, Mexico)

•                    Latin America- (Brazil, Argentina, Chile, Rest of Latin America)

•                    Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA)

Market Research Community

Email: sales@marketresearchcommunity.com

Contact no.: (US) +1-214-272-0393

 (UK) +44-20-8133-9198